FERMENTA vs RUBICON: Stock Comparison

Fermenta Biotech Ltd vs Rubicon Research Limited

Live data: 24 July 2026, 4:08 PM IST • Source: NSE and company filings

Rubicon Research Limited is the larger company by market capitalisation. Fermenta Biotech Ltd shows a lower P/E and a higher dividend yield, while Rubicon Research Limited shows a higher ROE, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Fermenta Biotech Ltd and Rubicon Research Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, FERMENTA is more favourable on 4 of 13 scored metrics and RUBICON on 9These counts are context-free and are not an overall rating.

Key Differences

Market Cap
RUBICON is the larger company
₹25,045 Cr vs ₹1,272 Cr
P/E Ratio
FERMENTA has a lower P/E
18.14x vs 101.81x
P/B Ratio
FERMENTA has a lower P/B
3.14x vs 19.5x
EPS
FERMENTA has higher earnings per share
₹24.4 vs ₹15.48
Dividend Yield
FERMENTA has a higher dividend yield
0.62% vs 0%
Revenue Growth (TTM YoY)
RUBICON has faster revenue growth
43.5% vs 0%
EPS Growth (TTM YoY)
RUBICON has faster EPS growth
96.6% vs 0%
Qtr Sales Growth
RUBICON has stronger quarterly sales growth
43.5% vs -13.1%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricFERMENTARUBICON
SectorHealthcare
IndustryPharmaceuticals

Price

MetricFERMENTARUBICON
Live Price₹432.05₹1,520.2
Day Change7.74%-0.34%
Volume2.13 L1.84 L
52-Week High₹479.45₹1,547.3
52-Week Low₹248.85₹570.75
Distance from 52W High-9.89%-1.75%

Valuation

MetricFERMENTARUBICON
Market Cap₹1,272 Cr₹25,045 Cr
P/E Ratio18.14x101.81x
P/B Ratio3.14x19.5x
EPS₹24.4₹15.48
Book Value₹138₹78.22
Dividend Yield0.62%0%

Growth

MetricFERMENTARUBICON
Revenue Growth (TTM YoY)0%43.5%
EPS Growth (TTM YoY)0%96.6%
Qtr Sales Growth-13.1%43.5%
Qtr Profit Growth-62.9%112%

Profitability & Leverage

MetricFERMENTARUBICON
ROE17.4%27%
ROCE20.4%28.4%
Net Margin13.37%13.48%
Operating Margin19%22.8%
Debt to Equity0.28x0.24x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricFERMENTARUBICON
Promoter Holding56.47%23.97% 0.05 pp
FII Holding0.02%7.54% 0.45 pp
DII Holding0%10.02% 0.57 pp
Public Holding33.3% 0.69 pp22.58% 0.01 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Fermenta Biotech Ltd and Rubicon Research Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.